Abstract
Background
In the past decade, a strong argument has been built for the role of serotonin (5HT) and the serotonin transporter (SERT) in irritable bowel syndrome (IBS). However, it is still not clear how SERT contributes to this clinically heterogeneous disease. The present study addressed this issue by implementing platelet (plt) markers of SERT activity in the assessment protocol.
Methods
Fasting blood samples of 149 (51 male/98 female) subjects with Rome II and III defined IBS subtypes, and 163 healthy control subjects (CSs; 75 male/88 female) were analyzed for platelet 5HT concentration and 5HT uptake activity [maximum uptake rate (V max) and affinity constant (K m)].
Results
Gender had a significant impact on platelet markers of SERT activity. Male IBS patients showed significantly lower median V max and K m values than the male CS (V max 1.706 vs. 2.148 nmol/109 plts × min, P < 0.001; K m 346 vs. 410 nmol, P = 0.008) without any significant reduction in platelet 5HT concentration (362 vs. 394 ng/109 plts). On the other hand, V max values were not different between female IBS patients and female CS (1.642 vs. 1.741 nmol/109 plts × min), but platelet 5HT concentration was significantly lower in females with diarrhea-predominant IBS (363 vs. 435 ng/109 plts, P < 0.05).
Conclusion
Although an absolute extrapolation from platelets to the gastrointestinal tissue does not appear to be justified, our findings demonstrated that the contribution of disturbed SERT activity to IBS is not uniform and is possibly gender-specific. The results suggest that an assessment of SERT function in platelets may help to elucidate the differences between IBS patients in response to drugs affecting the 5HT system.
Similar content being viewed by others
References
Kim DY, Camilleri M. Serotonin: a mediator of the brain-gut connection. Am J Gastroenterol. 2000;95(10):2698–709.
Crowell MD. Role of serotonin in the pathophysiology of the irritable bowel syndrome. Br J Pharmacol. 2004;141(8):1285–93.
Blundell JE, Lawton CL, Halford JC. Serotonin, eating behavior, and fat intake. Obes Res. 1995;3(Suppl 4):471S–6S.
Lucki I. The spectrum of behaviours influenced by serotonin. Biol Psychiatry. 1998;44(3):151–62.
Bengel D, Jöhren O, Andrews AM, Heils A, Mössner R, Sanvitto GL, et al. Cellular localization and expression of the serotonin transporter in mouse brain. Brain Res. 1997;778(2):338–45.
Wade PR, Chen J, Jaffe B, Kassem IS, Blakely RD, Gershon MD. Localization and function of a 5-HT transporter in crypt epithelia of the gastrointestinal tract. J Neurosci. 1996;16(7):2352–64.
Chen JX, Pan H, Rothman TP, Wade PR, Gershon MD. Guinea pig 5-HT transporter: cloning, expression, distribution, and function in intestinal sensory reception. Am J Physiol. 1998;275(3 Pt 1):G433–48.
Torres GE, Gainetdinov RR, Caron MG. Plasma membrane monoamine transporters: structure, regulation and function. Nat Rev Neurosci. 2003;4(1):13–25.
Chen JJ, Li Z, Pan H, Murphy DL, Tamir H, Koepsell H, et al. Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: abnormal intestinal motility and the expression of cation transporters. J Neurosci. 2001;21(16):6348–61.
Coates MD, Mahoney CR, Linden DR, Sampson JE, Chen J, Blaszyk H, et al. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology. 2004;126(7):1657–64.
Camilleri M, Andrews CN, Bharucha AE, Carlson PJ, Ferber I, Stephens D, et al. Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome. Gastroenterology. 2007;132(1):17–25.
Kerckhoffs AP, Ter Linde JJ, Akkermans LM, Samsom M. Trypsinogen IV, serotonin transporter transcript levels and serotonin content are increased in small intestine of irritable bowel syndrome patients. Neurogastroenterol Motil. 2008;20(8):900–7.
Spiller R, Bennett A. Searching for the answer to irritable bowel syndrome in the colonic mucosa: SERTainty and unSERTainty. Gastroenterology. 2007;132(1):437–41.
Camilleri M. Is there a SERT-ain association with IBS? Gut. 2004;53(10):1396–9.
Ortiz J, Artigas F, Gelpi E. Serotonergic status in human blood. Life Sci. 1988;43:983–90.
Franke L, Schewe H-J, Müller B, Campman V, Kitzrow W, Uebelhack R, et al. Serotonergic platelet variables in unmedicated patients suffering from major depression and healthy subjects. Relationship between 5HT content and 5HT uptake. Life Sci. 2000;67:301–15.
Cicin-Sain L, Froebe A, Bordukalo-Niksic T, Jernej B. Serotonin transporter kinetics in rats selected for extreme values of platelet serotonin level. Life Sci. 2005;77(4):452–61.
Franke L, Schewe H-J, Uebelhack R, Müller-Oerlinghausen B. High platelet 5HT uptake activity is associated with a rapid response in depressed patients treated with amitriptyline. Neurosci Lett. 2003;345:105–8.
Franke L, Schewe H-J, Uebelhack R, Berghöfer A, Müller-Oerlinghausen B. Platelet-5HT uptake and gastrointestinal symptoms in patients suffering from major depression. Life Sci. 2003;74:521–31.
Herwig TA, Farstad M, Vollset SE. Endogeneous serotonin in human blood platelets—factors that may influence reference values. Platelets. 1996;7:47–52.
Hrdina PD, Bakish D, Ravindran A, Chudzik J, Cavazzoni P, Lapierre YD. Platelet serotonergic indices in major depression: upregulation of 5-HT2A receptors unchanged by antidepressant treatment. Psychiatry Res. 1997;66:73–85.
Mück-Seler D, Jakovljevic M, Pivac N. Platelet 5HT concentrations and suicidal behaviour in recurrent major depression. J Affect Disord. 1996;39:73–80.
Neuger J, El Khoury A, Kjellman BF, Wahlund B, Aberg-Wistedt A, Stain-Malmgren R. Platelet serotonin functions in untreated major depression. Psychiatry Res. 1999;85(2):189–98.
Atkinson W, Lockhart S, Whorwell PJ, Keevil B, Houghton LA. Altered 5-hydroxytryptamine signalling in patients with constipation- and diarrhoea-predominant irritable bowel syndrome. Gastroenterology. 2006;130(1):34–43.
Dunlop SP, Coleman NS, Blackshaw E, Perkins AC, Singh G, Marsden CA, et al. Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin Gastroenterol Hepatol. 2005;3(4):349–57.
Houghton LA, Atkinson W, Whitaker RP, Whorwell PJ, Rimmer MJ. Increased platelet depleted plasma 5-hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndrome. Gut. 2003;52(5):663–70.
Bellini M, Rappelli L, Blandizzi C, Costa F, Stasi C, Colucci R, et al. Platelet serotonin transporter in patients with diarrhea-predominant irritable bowel syndrome both before and after treatment with alosetron. Am J Gastroenterol. 2003;98(12):2705–11.
Guicheney P. Human platelet serotonin content: methodological aspects and physiological variations. Methods Find Exp Clin Pharmacol. 1988;10:253–8.
Martin F, Rozas G, Miguez J, Aldegunde M. Plasma serotonin: factors affecting its levels. Biog Amines. 1999;7:57–62.
Payne S. Sex, gender, and irritable bowel syndrome: making the connections. Gend Med. 2004;1(1):18–28.
Heitkemper M, Jarrett M, Bond EF, Chang L. Impact of sex and gender on irritable bowel syndrome. Biol Res Nurs. 2003;5(1):56–65.
Flachaire E, Beney C, Berthier A, Salandre J, Quincy C, Renaud B. Determination of reference values for serotonin concentration in platelets of healthy newborns, children, adults, and elderly subjects by HPLC with electrochemical detection. Clin Chem. 1990;36:2117–20.
Kema IP, Vries EGE, Muskiet FAJ. Clinical chemistry of serotonin and metabolites. J Chromatogr B Biomed Sci Appl. 2000;747:33–48.
Müller-Oerlinghausen B, Roggenbach J, Franke L. Serotonergic platelet markers of suicidal behaviour—do they really exist? J Affect Disord. 2004;79(1–3):13–24.
Heaton KW, Radvan J, Cripps H, Mountford RA, Braddon FE, Hughes AO. Defecation frequency and timing, and stool form in the general population: a prospective study. Gut. 1992;33(6):818–24.
Hinds JP, Stoney B, Wald A. Does gender or the menstrual cycle affect colonic transit? Am J Gastroenterol. 1989;84(2):123–6.
Meier R, Beglinger C, Dederding JP, Meyer-Wyss B, Fumagalli M, Rowedder A, et al. Influence of age, gender, hormonal status and smoking habits on colonic transit time. Neurogastroenterol Motil. 1995;7(4):235–8.
Talley NJ, Boyce P, Owen BK. Psychological distress and seasonal symptom changes in irritable bowel syndrome. Am J Gastroenterol. 1995;90(12):2115–9.
Douglas WW. Histamine and 5-hydroxytryptamine (serotonin) and their antagonists. In: Gilman AG, Goodman LS, Gilman A, editors. The pharmacological basis of therapeutics. 6th ed. ed. New York: Macmillan; 1980. p. 609–46.
Anderson GM, Stevenson JM, Cohen DJ. Steady-state model for plasma free and platelet serotonin in man. Life Sci. 1987;41(15):1777–85.
Miwa J, Echizen H, Matsueda K, Umeda N. Patients with constipation-predominant irritable bowel syndrome (IBS) may have elevated serotonin concentrations in colonic mucosa as compared with diarrhea-predominant patients and subjects with normal bowel habits. Digestion. 2001;63(3):188–94.
Author information
Authors and Affiliations
Corresponding author
Additional information
An erratum to this article can be found at http://dx.doi.org/10.1007/s00535-010-0212-x
Rights and permissions
About this article
Cite this article
Franke, L., Schmidtmann, M., Riedl, A. et al. Serotonin transporter activity and serotonin concentration in platelets of patients with irritable bowel syndrome: effect of gender. J Gastroenterol 45, 389–398 (2010). https://doi.org/10.1007/s00535-009-0167-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00535-009-0167-y